Challenges and Opportunities - How EASD Turned Global
Diabetes Insights - Breakthroughs and InnovatorsShow Notes
In this episode, former EASD President Prof. Stefano Del Prato joins host Vivienne Parry to reflect on leading EASD during the unprecedented challenges of the COVID-19 pandemic.
He shares how EASD rapidly transformed its Annual Meeting into a successful virtual event, unexpectedly reaching more than 20,000 participants worldwide and strengthening connections with the global diabetes community. The conversation explores how these experiences led to the creation of the EASD Global Council, expanded international collaboration and new initiatives that continue to shape the organisation today.
Prof. Del Prato also discusses the enduring value of face-to-face scientific meetings, the importance of bringing researchers together and the innovations that continue to make the EASD Annual Meeting one of the world's leading diabetes conferences.
More from Diabetes Insights - Breakthroughs and Innovators
In this EASD TV interview, Prof. Zachary Gerhart-Hines (Novo Nordisk Foundation Center for Basic Metabolic Research), 61st EASD Minkowski Prize recipient, discusses research into the neurokinin-2 receptor (NK2R) and its potential to change how we approach weight management and metabolic health. Where many existing treatments focus on reducing food intake, NK2R activation could offer a complementary strategy by increasing energy expenditure, influencing appetite and improving insulin sensitivity.
How does exercise stimulate glucose uptake in muscle and what can this teach us about treating type 2 diabetes?
Prof. Anette-Gabriele Ziegler, this year’s Claude Bernard Prize Lecture recipient, reflects on her career in type 1 diabetes research and the evolution of our understanding of the disease.
The EASD’s first clinical practice guideline on the assessment and management of diabetes distress in adults living with type 1 or type 2 diabetes has now been published in Diabetologia.
How can people living with diabetes help shape the future of diabetes care?